Report Categories
View AllRecent Articles
View All
Is Qiagen QGEN building a durable competitive moat Institutional Selling 20260507
Market Update Tech leads market gains while consumer sector trails
EON Resources EONR Entry Point Q1 2025 EPS Beats Forecasts
What LiveRamp Holdings RAMP does that makes it resilient 248 20260508
Amgen Inc AMGN Q1 2026 Earnings Robust Growth Pipeline Offsets Legacy Product Pressures
Aon plc AON Expands Data Center Lifecycle Insurance Capacity to 35B Assessing Strategic Upside for Digital Infrastructure Market Position
NLOP Net Lease signals focus on highyield office property acquisitions to drive longterm revenue growth
Bond Bull Market May Pause but Remains Intact Expert Suggests
CryoCell CCEL Q1 2026 Earnings Surprise EPS 001 Up Significant
Blanche Denies Trump Involvement in 18 Billion Fund Settlement as Report Reveals IRS Legal Opposition
Grid GDYN Q1 2026 Earnings EPS 009 Beats Estimates
Anesthesiologist Assistant Prioritizes WorkLife Balance Over Potential 500K Income
Tesla Launches Full SelfDriving Supervised in China Aiming to Catch Up with Local EV Rivals
Nuclear Verdict Alert Nearly 50 Million Awarded Against Unnamed Texas Trucking Company
Tulsi Gabbard Resigns as US Intelligence Chief Amid Iran Strike Considerations
Align Technology Plans 200 Million Manufacturing Facility in India
Miivo Holdings Commences Trading on Frankfurt Stock Exchange
MCHPP Q1 2026 Earnings EPS Surpasses Expectations by 106 Amidst Mixed Market Conditions
IEP Q1 2026 Earnings Significant EPS Miss vs Estimates
iSpecimen Inc ISPC Q3 2024 Earnings Wide EPS Miss Amid Operational Challenges
IMVT Q1 2026 Earnings EPS Misses Estimates Stock Slightly Positive Amid Development Progress
Purple Innovation Inc PRPL Q1 2026 Earnings EPS Meets Estimates with Narrow Beat Shares Edge Lower
PHI Q1 2026 Earnings EPS Misses Estimates Amid Narrow Miss Stock Edges Higher
Netcapital Inc NCPL Edges Lower Testing Support Near Key Inflection Point
MBIA Inc MBI Edges Higher Amid Steady Trading as Shares Test Key Resistance
Sera Prognostics Surges 15 Key Resistance in Sight for SERA
Darling Ingredients DAR Posts Modest Gains as Technical Support Holds
Inhibikase Therapeutics IKT Dips 287 as Stock Approaches Critical Support at 161